An observational study in Community Acquired Infection, sponsored by Jian-cang Zhou M.D.. Completed at 1 site in China. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2015-11-23.
Sponsored by Jian-cang Zhou M.D. · Observational
Escherichia coli is the leading cause of community-onset gram-negative bloodstream infections. There has been a dramatic increase in the prevalence of extended-spectrum b-lactamases producing E. coli and K.pneumoniae in the community, which was considered to be exclusively a nosocomial pathogen in recent years. As a result, the treatment options for community-onset infections due to ESBL-producing E. coli or K.pneumoniae are limited and the initial empirical therapy is often ineffective and associated with increased mortality. Although there were some reports of the risk factors of community-onset ESBL producing E. coli in Spain, Korea, and Canada, few empirical data were available about China. Therefore, the investigators aim was to investigate the epidemiology, risk factors, and the hospital outcomes for patients with community-onset bacteremia caused by ESBL producing E. coli or K.pneumoniae in China.
Eligibility criteria:
Outcome measures:
2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.
This study's enrollment of 960 is above the median of 203 across 688 observational studies indexed under Pneumonia.
Browse Pneumonia studies →This is the only study on the registry with Jian-cang Zhou M.D. as lead sponsor.
Counted across the registry records on this site, refreshed daily.
All adult patients visited any of the 28 particitant hospitals during the study period were screened. Patients with community-onset bacteremia caused by E.coli or K. pneumoniae and without a recent hospitalization in any hospital will be included
Exclusion Criteria:
Case Patients with Community-Onset Bacteremia Due toESBL producing E.coli or K.pneumoniae
Other: bacteremia caused by ESBL producing E.coli or K.pneumoniae
bacteremia caused by ESBL producing E.coli or K.pneumoniae
community-onset bacteremia caused by ESBL producing E.coli or K.pneumoniae
Risk factors for community-onset bacteremia caused by ESBL producing E.coli or K.pneumoniae
Time frame: one year
This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.